A New York State Supreme Court judge has dismissed a shareholder lawsuit against the Sequoia Fund and its board over the fund’s concentrated position in the embattled prescription drug company Valeant Pharmaceuticals International. “The fund’s independent directors are gratified that the New York State Court accepted our arguments and recognized...